In 2016 was created CQY Capital, which is appeared as VC. The company was established in Asia in China. The main office of represented VC is situated in the Shanghai.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2018.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Linmon Pictures. Among the most successful fund investment fields, there are Film, Digital Entertainment.
The typical case for the fund is to invest in rounds with 5 participants. Despite the CQY Capital, startups are often financed by Tencent Holdings, Mango V Foundation, Hony Capital. The meaningful sponsors for the fund in investment in the same round are Tencent Holdings, Hony Capital, Hanfor (Beijing) Capital Management.
Funds with similar focus
Fund Name | Location |
ASCIL Biopharm | - |
Avalon Capital Group | California, La Jolla, United States |
Beijing Lanhai Wentong Zixun Fuwu Youxian Gongsi | Beijing, China, Shunyi |
Brooklands Capital Strategies | California, San Francisco, United States |
ChangePartners | Brazil, Rio Grande do Sul, Viamão |
Chenchuang Lihe Touzi | Beijing, Beijing, China |
Dyal Capital Partners | New York, New York, United States |
Emergya Ventures | Andalucia, Seville, Spain |
First International Computer | New Taipei, Taiwan |
Forum Capital Partners | New York, New York, United States |
Hangzhou Ruizhao Investment Management | - |
Kipo | Guatemala, Guatemala City |
Lavni Ventures | - |
MagiCapital | Taipei, Taiwan |
Malpani Ventures | Colaba, India, Maharashtra |
MenschDanke Group | Berlin, Berlin, Germany |
Ningbo Meishan Baoshui Gangqu Shuanghao Guquan Touzi | Beilun, China, Zhejiang |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhongze Therapeutics | 21 Apr 2022 | - | |||
Linmon Pictures | 12 Mar 2018 | Shanghai, China | |||
Motie.com | $46M | 04 Jul 2017 | Dongcheng District, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhongze Therapeutics | 21 Apr 2022 | - | |||
Linmon Pictures | 12 Mar 2018 | Shanghai, China | |||
Motie.com | $46M | 04 Jul 2017 | Dongcheng District, Beijing, China |